LONG-TERM THERAPY WITH BEZAFIBRATE AND URSODEOXYCHOLIC ACID IS INSUFFICIENT FOR PREVENTING DISEASE PROGRESSION IN PATIENTS WITH ADVANCED PRIMARY BILIARY CIRRHOSIS

被引：4
|
作者：
Reig, A. [1 ]
Sese, P. [1 ]
Pares, A. [1 ]
机构：
[1] Univ Barcelona, C1BERehd, IDIBAPS, Liver Unit,Hosp Clin, Barcelona, Spain
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)31397-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1201
引用
收藏
页码：S806 / S806
页数：1
相关论文
共 50 条
  • [1] Primary biliary cirrhosis: long-term therapy with ursodeoxycholic acid
    Poupon, R
    Corpechot, C
    Carrat, F
    Poupon, RE
    [J]. CHOLESTATIC LIVER DISEASES: THERAPEUTIC OPTIONS AND PERSPECTIVES: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 136 : 171 - 178
  • [2] Long-term bezafibrate therapy does not prevent the progression of primary biliary cholangitis in patients with advanced disease
    Reig, Anna
    Patricia Llovet, Laura
    Sese, Pilar
    Carlota Londono, Maria
    Pares, Albert
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E407 - E407
  • [3] Long-term ursodeoxycholic acid therapy delays histologic progression in primary biliary cirrhosis.
    Angulo, P
    Batts, KP
    Therneau, TM
    Jorgensen, RA
    Dickson, ER
    Lindor, KD
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A1203 - A1203
  • [4] Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis
    Angulo, P
    Batts, KP
    Therneau, TM
    Jorgensen, RA
    Dickson, ER
    Lindor, KD
    [J]. HEPATOLOGY, 1999, 29 (03) : 644 - 647
  • [5] What is the influence of long-term ursodeoxycholic acid therapy in patients with primary biliary cirrhosis?
    Clark, Virginia C.
    Levy, Cynthia
    [J]. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2007, 4 (04): : 188 - 189
  • [6] What is the influence of long-term ursodeoxycholic acid therapy in patients with primary biliary cirrhosis?
    Virginia C Clark
    Cynthia Levy
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 : 188 - 189
  • [7] IgM Level Predicts Long-Term Prognosis in Patients With Primary Biliary Cirrhosis Treated With Ursodeoxycholic Acid and Bezafibrate
    Takano, Keiko
    Saeki, Chisato
    Nakagawa, Ryo
    Hokari, Atsushi
    Ishikawa, Tomohisa
    Tajiri, Hisao
    Zeniya, Mikio
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S1060 - S1060
  • [8] A Prospective Randomized Controlled Study of Long-Term Combination Therapy Using Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis and Dyslipidemia
    Hosonuma, Kenichi
    Sato, Ken
    Yamazaki, Yuichi
    Yanagisawa, Masatoshi
    Hashizume, Hiroaki
    Horiguchi, Norio
    Kakizaki, Satoru
    Kusano, Motoyasu
    Yamada, Masanobu
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (03): : 423 - 431
  • [9] Long-term ursodeoxycholic acid treatment delays progression of mild primary biliary cirrhosis
    Pares, A
    Caballeria, L
    Rodes, J
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 187 - 188
  • [10] Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis
    Levy, C
    Angulo, P
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (02): : 269 - 270
12345